Implementing a spatial and single-cell multiplexed platform for developed of targeted therapies for vascularized composite allotransplantation
Active Project Grant Awarded Last action
- Award ID
- HT94252410931
- Recipient
-
The Leland Stanford Junior University UEI HJD6G4D6TJY5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $750,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 72% complete
- Place of performance
- Palo Alto, CA 94305, USA
Award details come from USAspending.gov.
About this award
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $750,000 Project Grant to Stanford University to implement a spatial and single-cell multiplexed platform for the development of targeted therapies for vascularized composite allotransplantation. The funding is provided through the Military Medical Research and Development (CFDA 12.420) federal grant program, which supports advanced biomedical research to transform healthcare for military service members and the broader public. This 3-year project, beginning on September 1, 2024 and ending on August 31, 2027, aims to develop innovative medical technologies and treatment approaches for conditions relevant to military personnel and veterans.
Quick answers
Who received award HT94252410931?
HT94252410931 was awarded to The Leland Stanford Junior University by Defense Health Agency (Department of Defense) on September 1, 2024.
How much is award HT94252410931 worth?
$750,000 has been obligated on HT94252410931.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award